Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Small RNA discovery in developing mouse and during human in vitro beta-cell differentiation protocol

ABSTRACT: Small RNA discovery in developing mouse and during human in vitro beta-cell differentiation protocol

PROVIDER: PRJEB9078 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR850603_1.fastq.gz	Fastqsanger.gz
	ERR850603_2.fastq.gz	Fastqsanger.gz
	ERR850604_1.fastq.gz	Fastqsanger.gz
	ERR850604_2.fastq.gz	Fastqsanger.gz
	ERR850605_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

Small RNA discovery in developing mouse and during human in vitro beta-cell differentiation protocol

Project description:The aim of this experiment was to identify novel, small (<600bp), capped, polyA-tailed RNA transcripts in mouse E14.5 pancreas, liver, and brain and at stages S1, S2, S3 within our human in vitro beta-cell differentiation protocol. Low-molecular-weight (LMW) and high-molecular-weight (HMW) fractions were separated.

2015-04-02 | E-MTAB-3489 | biostudies-arrayexpress

Generation of functional human pancreatic beta cells in vitro

2014-09-25 | GSE61714 | GEO

Generation of functional human pancreatic beta cells in vitro

Project description:The generation of insulin-producing pancreatic cells from stem cells in vitro would provide an unprecedented cell source for drug discovery and cell transplantation therapy in diabetes. However, insulin-producing cells previously generated from human pluripotent stem cells (hPSC) lack many functional characteristics of bona fide β cells. Here we report a scalable differentiation protocol that can generate hundreds of millions of glucose-responsive β cells from hPSC in vitro. These stem cell derived cells (SC) express markers found in mature β cells, flux Ca2+ in response to glucose, package insulin into secretory granules and secrete quantities of insulin comparable to adult β cells in response to multiple sequential glucose challenges in vitro. Furthermore, these cells secrete human insulin into the serum of mice shortly after transplantation in a glucose-regulated manner, and transplantation of these cells ameliorates hyperglycemia in diabetic mice. Differentiated cells were sorted and processed for RNA isolation using the MARIS protocol published previously (PMID: 24516164.) Human embryonic stem cell (hESC) line HUES8 was differentiated into SC-beta cells. Two biological replicates were analyzed. Those data were normalized together with and compared to existing, previously published data from Hrvatin et al. ( (PMID: 24516164) from human islet -derived insulin+ cells, undifferentiated HUES8 hES cells, and insulin+ cells derived from HUES8 cells according to previously published protocols.

2014-09-25 | E-GEOD-61714 | biostudies-arrayexpress

Tissue Procurement Protocol

Project description:Tissue Procurement Protocol

| PRJNA819531 | ENA

WGA protocol optimization

Project description:WGA protocol optimization

| PRJEB34940 | ENA

Discovery

Project description:Discovery

| OEX00013698 | NODE

A CellAge epigenetic clock for expedited discovery of anti-ageing compounds in vitro

Project description:We aim to improve anti-ageing drug discovery, currently achieved through laborious and lengthy longevity analysis. Recent studies demonstrated that the most accurate molecular method to measure human age is based on CpG methylation profiles, as exemplified by several epigenetics clocks that can accurately predict an individual’s age. Here, we developed CellAge, a new epigenetic clock that measures subtle ageing changes in primary human cells in vitro. As such it provides a unique tool to measure effects of relatively short pharmacological treatments on ageing. We validated our CellAge clock against known longevity drugs such as rapamycin and trametinib. Moreover, we uncovered novel anti-ageing drugs, torin2 and Dactolisib (BEZ-235), demonstrating the value of our approach as a screening and discovery platform for anti-ageing strategies. CellAge outperforms other epigenetic clocks in measuring subtle ageing changes in primary human cells in culture. The tested drug treatments reduced senescence and other ageing markers, further consolidating our approach as a screening platform. Finally, we showed that the novel anti-ageing drugs we uncovered in vitro, indeed increased longevity in vivo. Our method expands the scope of CpG methylation profiling from measuring human chronological and biological age from human samples in years, to accurately and rapidly detecting anti-ageing potential of drugs using human cells in vitro, providing a novel accelerated discovery platform to test sought after geroprotectors.

2021-10-01 | E-MTAB-8327 | biostudies-arrayexpress

Paired end protocol test

Project description:Paired end protocol test

| PRJEB2279 | ENA

Transcriptome dynamics in early in vivo developing and in vitro produced porcine embryos

Project description:Transcriptome dynamics in early in vivo developing and in vitro produced porcine embryos

| PRJNA648324 | ENA

Single cell transcriptional profiling of cultured developing neurons upon inflammatory challenge [in vitro]

Project description:Single cell transcriptional profiling of cultured developing neurons upon inflammatory challenge [in vitro]

| PRJNA541482 | ENA